Volume 19 Issue 1
Jan.  2021
Turn off MathJax
Article Contents
LIU Shi-hua, ZHANG Chao, TIAN Zhi-gang, HOU Wen-zhe, ZHONG Ping. Expression and clinical significance of serum S-100β protein in patients with white matter ischaemic lesions[J]. Chinese Journal of General Practice, 2021, 19(1): 38-41. doi: 10.16766/j.cnki.issn.1674-4152.001724
Citation: LIU Shi-hua, ZHANG Chao, TIAN Zhi-gang, HOU Wen-zhe, ZHONG Ping. Expression and clinical significance of serum S-100β protein in patients with white matter ischaemic lesions[J]. Chinese Journal of General Practice, 2021, 19(1): 38-41. doi: 10.16766/j.cnki.issn.1674-4152.001724

Expression and clinical significance of serum S-100β protein in patients with white matter ischaemic lesions

doi: 10.16766/j.cnki.issn.1674-4152.001724
Funds:

 1804h08020258

 SZ2017GG43

  • Received Date: 2020-07-24
    Available Online: 2022-02-19
  •   Objective  To explore the expression level of serum S-100β protein in patients with white matter ischaemic lesions (WMIL) and its relationship with WMIL.  Methods  Patients with WMIL, as confirmed by craniocerebral magnetic resonance, from June 2017 to September 2019 were selected as the research subjects, and the degree of white matter lesions was evaluated on the basis of the Fazekas rating scale. Those with normal craniocerebral magnetic resonance matched with age and sex during the same period were selected as the control group. Serum S-100β protein concentrations were detected with enzyme-linked immunosorbent assays. The general clinical data and S-100β protein levels were compared between the two groups. Spearman rank correlation was used to analyse the relationship between the serum S-100β protein level and degree of white matter lesions, and multivariate Logistic regression was used to analyse the influencing factors of WMIL.  Results  Compared with the control group, the proportion of patients with hypertension (79.1% vs. 42.0%, P < 0.001), the proportion of patients with diabetes (34.8% vs. 15.9%, P=0.006) and the level of S-100β protein [(1.414±0.260) pg/mL vs. (0.961±0.316) pg/mL, P < 0.001] in the WMIL group were significantly higher, and the differences were statistically significant. The serum S-100β protein level of patients in WMIL group was significantly and positively correlated with the Fazekas score (r=0.736, P < 0.001). Multivariate logistic regression analysis showed that hypertension, diabetes and elevated S-100β protein levels were independent risk factors for WMIL (all P < 0.01).  Conclusion  The expression level of serum S-100β protein is increased in WMIL patients and positively correlated with the severity of WMIL. The elevated serum S-100β protein level might be an independent risk factor for WMIL, which might be an effective biological marker of chronic white matter damage.

     

  • loading
  • [1]
    PANTONI L, FIERINI F, POGGESI A. Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions[J]. Geriatr Gerontol Int, 2015, 15(Suppl 1): 10-16. doi: 10.1111/ggi.12665/pdf
    [2]
    CHUTINET A, ROST N S. White matter disease as a biomarker for long-term cerebrovascu WMILr disease and dementia[J]. Curr Treat Options Cardiovasc Med, 2014, 16(3): 292. doi: 10.1007/s11936-013-0292-z
    [3]
    DOIT, SHIMADA H, MAKIZAKO H, et al. Effects of white matter lesions on trunk stability during dual-task walking among older adults with mild cognitive impairment[J]. Age (Dordr), 2015, 37(6): 120. doi: 10.1007/s11357-015-9858-x
    [4]
    RYU W S, WOO S H, SCHELLINGERHOUT D, et al. Stroke outcomes are worse with larger leukoaraiosis volumes[J]. Brain, 2017, 140(1): 158-170. doi: 10.1093/brain/aww259
    [5]
    CRISTÓVÀO J S, MORRIS V K, CARDOSO I, et al. The neuronal S-100β protein is a calcium-tuned suppressor of amyloid-β aggregation[J]. Sci Adv, 2018, 4(6): 1702. doi: 10.1126/sciadv.aaq1702
    [6]
    QIN B, PANICKAR K S, ANDERSON R A, et al. Cinnamon polyphenols attenuate the hydrogen peroxide-induced down regulation of S-100 beta secretion by regulating sirtuin 1 in C6 rat glioma cells[J]. Life Sci, 2014, 102(1): 72-79. doi: 10.1016/j.lfs.2014.02.038
    [7]
    LIU W, HUO X, LIU D, et al. S-100βprotein in heavy metal-related child attention-deficit hyperactivity disorder in an informal e-waste recycling area[J]. Neurotoxicology, 2014, 45: 185-191. doi: 10.1016/j.neuro.2014.10.013
    [8]
    GILSTON B A, SKAAR E P, CHAZIN W J, et al. Binding of transition metals to S-100 proteins[J]. Sci China Life Sci, 2016, 59(8): 792-801. doi: 10.1007/s11427-016-5088-4
    [9]
    WANG F, ZOU Z R, YUAN D, et al. Correlation between serum S100β protein levels and cognitive dysfunction in patients with cerebral small vessel disease: a case-control study[J]. Biosci Rep, 2017, 37(2): BSR20160446. doi: 10.1042/BSR20160446
    [10]
    ERCOLE A, THELIN E P, HOLST A, et al. Kinetic modelling of serum S100b after traumatic brain injury[J]. BMC Neurol, 2016, 16: 93. doi: 10.1186/s12883-016-0614-3
    [11]
    KOH S X, LEE J K. S100B as a marker for brain damage and blood-brain barrier disruption following exercise[J]. Sports Med, 2014, 44(3): 369-385. doi: 10.1007/s40279-013-0119-9
    [12]
    BRESNICK A R. S100 proteins as therapeutic targets[J]. Biophys Rev, 2018, 10(6): 1617-1629. doi: 10.1007/s12551-018-0471-y
    [13]
    LI K, JIA J, WANG Z, et al. Elevated Serum Levels of NSE and S-100β correlate with increased risk of acute cerebral infarction in Asian populations[J]. Med Sci Monit, 2015, 21: 1879-1888. doi: 10.12659/MSM.893615
    [14]
    DIMOPOULOS C, DAMASKOS C, PAPADAKIS M, et al. Expression of S-100βprotein in ischemia/reperfusion-induced brain injury after cyclosporine therapy: a biochemical serum marker with prognostic value?[J]. Med Sci Monit, 2019, 25: 1637-1644. doi: 10.12659/MSM.912810
    [15]
    ERCOLE A, THELIN E P, HOLST A, et al. Kinetic modelling of serum S-100βafter traumatic brain injury[J]. BMC Neurol, 2016, 16: 93. doi: 10.1186/s12883-016-0614-3
    [16]
    LU Y L, WANG R, HUANG H T, et al. Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population[J]. Sci Rep, 2018, 8(1): 971. doi: 10.1038/s41598-018-19156-w
    [17]
    KANAVAKI A, SPENGOS K, MORAKI M, et al. Serum Levels of S100β and NSE proteins in patients with non-transfusion-dependent thalassemia as biomarkers of brain ischemia and cerebral vasculopathy[J]. Int J Mol Sci, 2017, 18(12): 2724. doi: 10.3390/ijms18122724
    [18]
    RENSMA S P, VAN SLOTEN T T, LAUNER L J, et al. Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: a systematic review and meta-analysis[J]. Neurosci Biobehav Rev, 2018, 90: 164-173. doi: 10.1016/j.neubiorev.2018.04.003
    [19]
    BLAIR G W, HERNANDEZ M V, THRIPPLETON M J, et al. Advanced neuroimaging of cerebral small vessel disease[J]. Curr Treat Options Cardiovasc Med, 2017, 19(7): 56. doi: 10.1007/s11936-017-0555-1
    [20]
    黄瑞, 曹红. 缺血性脑白质疏松症病变部位危险因素分析[J]. 中国现代神经疾病杂志, 2018, 18(11): 830-836. doi: 10.3969/j.issn.1672-6731.2018.11.013
    [21]
    王晓霞, 徐燕. 原发性高血压患者24 h动态血压变异性与脑白质病变的相关性研究[J]. 中国实用医刊, 2019, 46(7): 89-91. https://www.cnki.com.cn/Article/CJFDTOTAL-LNXG201909006.htm
    [22]
    方立, 袁学谦, 张莉峰, 等. 血压变异干预策略对高血压脑白质疏松、预后卒中及认知的影响[J]. 中国现代医学杂志, 2019, 29(13): 103-108. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY201913020.htm
    [23]
    李复兴, 王荔. 脑白质病变与糖化血红蛋白及糖尿病年限的相关性研究[J]. 临床医药实践, 2015, 24(9): 695-698. https://www.cnki.com.cn/Article/CJFDTOTAL-SXLC201509021.htm
    [24]
    罗彦妮, 覃冬华, 钟良, 等. 缺血性脑白质病变患者发生认知功能障碍的影响因素分析[J]. 广西医学, 2018, 40(12): 1299-1301. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX201812009.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Article Metrics

    Article views (224) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return